APC and breast carcinoma: However, comprehensive genomic analysis revealed that activating mutations of certain Wnt/β-Catenin pathway components such as APC and β-Catenin were rarely observed in breast cancer, indicating that alternative mechanisms, probably Wnt-independent ways, exist to activate β-Catenin.